| 49273-6 |
Interpretation |
Imp |
Body fld |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Immunofixation for Body fluid Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49273-6 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Interpretation Fld IFE-Imp |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report |
2.54 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49274-4 |
Interpretation |
Imp |
Ser/Plas |
Pt |
Nar |
Immunoelectrophoresis |
|
ACTIVE |
Immunoelectrophoresis for Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49274-4 |
|
Immunoelectrophoresis |
|
|
Observation |
|
|
|
0 |
Interpretation SerPl IEP-Imp |
|
|
|
N |
|
Chemistry; IEP; Imm elect; Immunoelect; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SIE; SIEP; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49275-1 |
Interpretation |
Imp |
Ser/Plas |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Immunofixation for Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49275-1 |
|
Immunofixation |
|
|
Both |
|
|
|
0 |
Interpretation SerPl IFE-Imp |
|
|
|
N |
|
Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49276-9 |
Interpretation |
Imp |
Urine |
Pt |
Nar |
Immunofixation |
|
ACTIVE |
Immunofixation for Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49276-9 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Interpretation Ur IFE-Imp |
|
|
|
N |
|
Chemistry; Hematology; Heme; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49277-7 |
Interpretation |
Imp |
Urine |
24H |
Nar |
Immunofixation |
|
ACTIVE |
Immunofixation for 24 hour Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49277-7 |
|
Immunofixation |
|
|
Observation |
|
|
|
0 |
Interpretation 24h Ur IFE-Imp |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; IFE; Ifix; Immunofixation electrophoresis; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49278-5 |
Interpretation |
Imp |
Urine |
Pt |
Nar |
Immunoelectrophoresis |
|
ACTIVE |
Immunoelectrophoresis for Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49278-5 |
|
Immunoelectrophoresis |
|
|
Observation |
|
|
|
0 |
Interpretation Ur IEP-Imp |
|
|
|
N |
|
Chemistry; IEP; Imm elect; Immunoelect; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49279-3 |
Lactate dehydrogenase isoenzymes |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49279-3 |
|
|
|
|
Observation |
|
|
|
0 |
LDH Isos SerPl-Imp |
|
|
|
N |
|
2-Hydroxypropanoic acid; 2-hydroxy-propionate; 2-hydroxy-propionic acid; Chemistry; Dehydrog; Dehyrdogenase; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; ISO; Isoen; Isoenzyme; L.D.H; Lact; Lactic acid; Lactic acid dehydrogenase; LD; LDH; LDH Isos; L-lactate; L-lactate dehydrogenase; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4928-8 |
HLA-DPw5 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw5 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4928-8 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw5 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49280-1 |
Lipoprotein pattern |
Imp |
Ser/Plas |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Lipoprotein fractions [Interpretation] in Serum or Plasma by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49280-1 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
LP SerPl Elph-Imp |
|
|
|
N |
|
Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lip; Lipoprot; Lipoproteins; LP; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49281-9 |
Lipoprotein pattern |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Lipoprotein fractions [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49281-9 |
|
|
|
|
Observation |
|
|
|
0 |
LP SerPl-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lip; Lipoprot; Lipoproteins; LP; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49282-7 |
Metanephrine & Normetanephrine |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Metanephrine and Normetanephrine [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49282-7 |
|
|
|
|
Observation |
|
|
|
0 |
Metaneph+Normetaneph SerPl-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrne; Metenephrine; Narrative; Normeta; Normetaneph; Normetanephrn; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49283-5 |
Metanephrine & Normetanephrine |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Metanephrine and Normetanephrine [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49283-5 |
|
|
|
|
Observation |
|
|
|
0 |
Metaneph+Normetaneph Ur-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Metaneph; Metaneph+Normetaneph; Metanephrine fractionated; Metanephrne; Metenephrine; Narrative; Normeta; Normetaneph; Normetanephrn; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49284-3 |
Oligosaccharides pattern |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Oligosaccharides pattern [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49284-3 |
|
|
|
|
Observation |
|
|
|
0 |
Oligosaccharide Pattern Ur-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Oligosaccharide Pattern; Oligosaccharidoses; Point in time; Random; Report; UA; UR; Urn |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49285-0 |
Organic acids pattern |
Imp |
CSF |
Pt |
Nar |
|
|
ACTIVE |
Organic acids pattern [Interpretation] in Cerebral spinal fluid Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49285-0 |
|
|
|
|
Observation |
|
|
|
0 |
Organic Acids Pattern CSF-Imp |
|
|
|
N |
|
Acd; Acid; Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49286-8 |
Organic acids pattern |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Organic acids pattern [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49286-8 |
|
|
|
|
Observation |
|
|
|
0 |
Organic Acids Pattern SerPl-Imp |
|
|
|
N |
|
Acd; Acid; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49287-6 |
Organic acids pattern |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Organic acids pattern [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49287-6 |
|
|
|
|
Observation |
|
|
|
0 |
Organic Acids Pattern Ur-Imp |
|
|
|
N |
|
Acd; Acid; Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49288-4 |
Parathyrin |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Parathyrin [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49288-4 |
|
|
|
|
Observation |
|
|
|
0 |
PTH SerPl-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49289-2 |
Porphyrins |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Porphyrins [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49289-2 |
|
|
|
|
Observation |
|
|
|
0 |
Porphyrins SerPl-Imp |
|
|
|
N |
|
Chemistry; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plasma; Plsm; Point in time; Porph; Porphyrin; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 4929-6 |
HLA-DPw5 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-DPw5 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4929-6 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-DPw5 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49290-0 |
Porphyrins |
Imp |
Stool |
Pt |
Nar |
|
|
ACTIVE |
Porphyrins [Interpretation] in Stool Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49290-0 |
|
|
|
|
Observation |
|
|
|
0 |
Porphyrins Stl-Imp |
|
|
|
N |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Porph; Porphyrin; Random; Report; Stl; Stool = Fecal |
2.21 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49291-8 |
Porphyrins |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Porphyrins [Interpretation] in Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49291-8 |
|
|
|
|
Observation |
|
|
|
0 |
Porphyrins Ur-Imp |
|
|
|
N |
|
Chemistry; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; Porph; Porphyrin; Random; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49292-6 |
Porphyrin fractions |
Imp |
Urine |
24H |
Nar |
|
|
ACTIVE |
Porphyrin fractions [Interpretation] in 24 hour Urine Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49292-6 |
|
|
|
|
Observation |
|
|
|
0 |
Porphyrin Fract 24h Ur-Imp |
|
|
|
N |
|
1 day; 24 hours; 24HR; Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Hematology; Heme; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Report; UA; UR; Urn |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49293-4 |
Protein fractions.oligoclonal bands |
Imp |
CSF |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49293-4 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Oligoclonal Bands CSF Elph-Imp |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Frac; Fract; Fraction; Fractionated; Fractionation; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; M-spikes; Narrative; Neuro; Neurology; Point in time; PR; Prot; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49294-2 |
Protein fractions.oligoclonal bands |
Imp |
Ser/Plas |
Pt |
Nar |
|
|
ACTIVE |
Oligoclonal bands [Interpretation] in Serum or Plasma Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49294-2 |
|
|
|
|
Observation |
|
|
|
0 |
Oligoclonal Bands SerPl-Imp |
|
|
|
N |
|
Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; M-spikes; Narrative; Pl; Plasma; Plsm; Point in time; PR; Prot; Random; Report; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.54 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49295-9 |
Protein pattern |
Imp |
CSF |
Pt |
Nar |
Electrophoresis |
|
ACTIVE |
Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis Narrative |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
49295-9 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Prot Pattern CSF Elph-Imp |
|
|
|
N |
|
Cerebral spinal fluid; Cerebrospinal Fl; Chemistry; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Neuro; Neurology; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Report; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
